Clickable Table

< back to the main pricing table

Generic Name	Brand Name	Strength	Dosing	90 Day Cost	Coverage	Comments	Category 1	Category 2
Rapid-acting insulin biosimilars	Admelog	100 U/ml	As dir	$65	BC / NIHB - Covered	Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).	B Hypoglycemic Agents	Insulin
Rapid-acting insulin biosimilars	Trurapi	100 U/ml	As dir	$65	BC / NIHB - Covered	Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).	B Hypoglycemic Agents	Insulin
Regular insulin	Novolin Toronto/Humulin R	100 U/ml	As dir	$70	BC / NIHB - Covered	Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).	B Hypoglycemic Agents	Insulin
Repaglinide	Gluconorm	1 mg	TID	$40	BC / NIHB - Covered		B Hypoglycemic Agents	Meglitinides
Canagliflozin	Invokana	100 mg	QD	$295	BC / NIHB - SA		B Hypoglycemic Agents	Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
Dapagliflozin Propanediol Monohydrate	Forxiga	10 mg	QD	$80	BC / NIHB - Covered		B Hypoglycemic Agents	Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
Empagliflozin	Jardiance	10 mg	QD	$290	BC - SA / NIHB - Covered		B Hypoglycemic Agents	Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
Gliclazide	Diamicron	80 mg	BID	$35	BC / NIHB - Covered		B Hypoglycemic Agents	Sulfonylureas
Gliclazide MR	Diamicron MR	30 mg MR	2 QD	$35	BC / NIHB - Covered		B Hypoglycemic Agents	Sulfonylureas
Glyburide	Diabeta	5 mg	BID	$25	BC / NIHB - Covered		B Hypoglycemic Agents	Sulfonylureas
Sitagliptin	Januvia	100 mg	QD	$95	BC / NIHB - SA		B Hypoglycemic Agents	Dipeptidylpeptidase-4 Inhibitors (DPP-4)
Lixisenatide	Adlyxine	0.02 mg SQ	QD	$405	BC - NC / NIHB - Covered		B Hypoglycemic Agents	Glucagon-like Peptide 1 Agonist (GLP-1)
Semaglutide	Ozempic	0.5 mg SQ	Once weekly	$720	BC / NIHB - SA		B Hypoglycemic Agents	Glucagon-like Peptide 1 Agonist (GLP-1)
Liraglutide	Victoza	1.2 mg SQ	QD	$730	BC / NIHB - NC		B Hypoglycemic Agents	Glucagon-like Peptide 1 Agonist (GLP-1)
Liraglutide	Victoza	1.8 mg SQ	QD	$1090	BC / NIHB - NC		B Hypoglycemic Agents	Glucagon-like Peptide 1 Agonist (GLP-1)
Basal insulin (Degludec)	Tresiba	100 U/ml	As dir	$135	BC / NIHB - Covered	Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).	B Hypoglycemic Agents	Insulin
Basal insulin (Detemir)	Levemir	100 U/ml	As dir	$140	BC / NIHB - Covered	Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).	B Hypoglycemic Agents	Insulin
Basal insulin (Glargine)	Lantus	100 U/ml	As dir	$120	BC - NC / NIHB - SA	Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).	B Hypoglycemic Agents	Insulin
Basal insulin (Glargine)	Toujeo	300 U/ml	As dir	$115	BC - NC / NIHB - Covered	Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).	B Hypoglycemic Agents	Insulin
Basal insulin biosimilar (Glargine)	Basaglar	100 U/ml	As dir	$100	BC / NIHB - Covered	Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).	B Hypoglycemic Agents	Insulin
Long-acting insulin	Novolin NPH/Humulin N	100 U/ml	As dir	$70	BC / NIHB - Covered	Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).	B Hypoglycemic Agents	Insulin
Rapid-acting insulin	Humalog	100 U/ml	As dir	$95	BC - NC / NIHB - SA	Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).	B Hypoglycemic Agents	Insulin
Rapid-acting insulin	Novorapid	100 U/ml	As dir	$85	BC - NC / NIHB - SA	Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).	B Hypoglycemic Agents	Insulin
Metformin	Glucophage	500 mg	2 BID	$25	BC / NIHB - Covered		B Hypoglycemic Agents	Biguanides
Metformin SR	Glumetza SR	1000 mg	2 QD	$290	BC - NC / NIHB - SA		B Hypoglycemic Agents	Biguanides
Linagliptin	Trajenta	5 mg	QD	$280	BC - SA / NIHB - Covered		B Hypoglycemic Agents	Dipeptidylpeptidase-4 Inhibitors (DPP-4)
Saxagliptin	Onglyza	5 mg	QD	$165	BC - SA / NIHB - Covered		B Hypoglycemic Agents	Dipeptidylpeptidase-4 Inhibitors (DPP-4)

Legend:

BC = Alberta Blue Cross, NIHB = Non-Insured Health Benefits for First Nations and Inuit, NC = Not covered, SA = special authorization